Fund Holdings — Bain Capital Life Sciences Investors, LLC

Total Portfolio Value:
$1.04B
Total Bought:
$166.01M
Total Sold:
$174.30M
Net Transaction:
-$8.29M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvalent Inc3,577,2673,577,2670$164.45M$263.25M25.23%+$98.80M
Newamsterdam Pharma Company
ORDINARY SHARES
10,473,91310,473,9130$96.88M$116.99M11.21%+$20.11M
Pharvaris N V
COM
4,784,6743,904,319-880,355$99.86M$109.52M10.50%+$9.66M
Disc Medicine, Inc.(IRON)1,332,5451,332,5450$62.60M$76.97M7.38%+$14.36M
Madrigal Pharmaceuticals, Inc.(MDGL)0324,619+324,619$0$75.11M7.20%+$75.11M
Savara Inc.(SVRA)14,232,75114,232,7510$53.80M$66.89M6.41%+$13.09M
Cabaletta Bio, Inc.(CABA)2,000,0002,000,0000$30.44M$45.40M4.35%+$14.96M
Annexon, Inc.(ANNX)5,701,9268,061,719+2,359,793$13.46M$36.60M3.51%+$23.14M
Revolution Medicines, Inc.(RVMD)01,112,396+1,112,396$0$31.90M3.06%+$31.90M
Tango Therapeutics, Inc.(TNGX)2,892,6632,892,6630$32.57M$28.64M2.74%-$3.93M
Natera, Inc.(NTRA)700,197400,197-300,000$30.98M$25.07M2.40%-$5.92M
Syros Pharmaceuticals Inc2,124,6942,749,808+625,114$8.39M$21.42M2.05%+$13.03M
Mersana Therapeutics Inc8,663,6738,663,6730$11.00M$20.10M1.93%+$9.10M
Solid Biosciences Inc3,130,4223,130,4220$7.89M$19.22M1.84%+$11.33M
Nurix Therapeutics, Inc.(NRIX)1,822,8831,822,8830$14.33M$18.81M1.80%+$4.48M
Marinus Pharmaceuticals Inc1,431,0581,431,0580$11.52M$15.56M1.49%+$4.04M
X4 Pharmaceuticals, Inc.(XFOR)15,960,58816,915,784+955,196$17.40M$14.18M1.36%-$3.21M
Arcutis Biotherapeutics, Inc.(ARQT)3,000,0003,000,0000$15.93M$9.69M0.93%-$6.24M
C4 Therapeutics, Inc.(CCCC)1,642,2101,642,2100$3.05M$9.28M0.89%+$6.22M
Invivyd, Inc.(IVVD)1,937,2071,937,2070$3.29M$7.63M0.73%+$4.34M
Atea Pharmaceuticals, Inc.(AVIR)2,485,6382,485,6380$7.46M$7.58M0.73%+$124.3K
Rapid Micro Biosystems, Inc.CL A(RPID)8,434,5608,434,5600$9.11M$6.24M0.60%-$2.87M
Nautilus Biotechnology, Inc.(NAUT)2,000,0002,000,0000$6.32M$5.98M0.57%-$340.0K
2seventy Bio Inc1,408,9011,331,801-77,100$5.52M$5.69M0.55%+$163.9K
Aclaris Therapeutics, Inc.(ACRS)3,400,0003,500,000+100,000$23.29M$3.67M0.35%-$19.61M
Xilio Therapeutics, Inc.(XLO)2,805,4132,805,4130$5.92M$1.54M0.15%-$4.38M
Newamsterdam Pharma CompanyW EXP 11 22 202
*W EXP 99/99/999
100,000100,0000$190.0K$313.0K0.03%+$123.0K
CARA THERAPEUTICS INCCOM23,6460-23,646$39.7K$0—-$39.7K
CRINETICS PHARMACEUTICALS INCOM(CRNX)1,275,5520-1,275,552$37.93M$0—-$37.93M
CYMABAY THERAPEUTICS INCCOM913,9690-913,969$13.63M$0—-$13.63M
DYNAVAX TECHNOLOGIES CORPCOM NEW915,0000-915,000$13.51M$0—-$13.51M
EQRX INCCOM10,003,5730-10,003,573$22.21M$0—-$22.21M
SPRINGWORKS THERAPEUTICS INCCOM3,081,3070-3,081,307$71.24M$0—-$71.24M
Page 1 of 1
Bain Capital Life Sciences Investors, LLC — 13F Holdings — Q4 2023 | TickerTrail